Registry of antithrombotic therapy in patients with atrial fibrillation under replacement with bioprosthetic valve. (Retrospective observational study)

Registry of antithrombotic therapy in patients with atrial fibrillation under replacement with bioprosthetic valve. (Retrospective observational study) - BPV-AF registry (Retro)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034198

Enrollment

200

Registered

2018-09-19

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with atrial fibrillation after replacement with bioprosthetic valve.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who 3 months have passed after replacement with bioprosthetic valve (Aortic or Mitral valve replacement, surgical operation or TAVI) 2) Patients who have been given the definitive diagnosis of atrial fibrillation 3) Patients who can collect the data satisfied both 1) and 2) over 6 months.

Exclusion criteria

Exclusion criteria: 1) Patients who were participating in an interventional study during the period for investigation 2) Patients who have a mechanical valve in their body

Design outcomes

Primary

Measure	Time frame
Development of stroke/systemic embolism and major bleeding during the observation period	—

Countries

Japan

Contacts

Public ContactMasanori Kondo

DAIICHI SANKYO RD NOVARE CO., LTD. Clinical Development Department

kondo.masanori.v8@rdn.daiichisankyo.co.jp03-5436-8544

Outcome results